<div xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../input-cache/schemas-r5/fhir-single.xsd">
  <p>
      This section contains documentation for implementers from both the clinical and technical
      perspectives. The process documentation describes the assumptions and decisions made, as well
      as a functional description of the recommendations. The integration documentation describes the
      overall approach and documents the artifacts contained in the IG, while the implementation
      documentation provides developer-level documentation on how to use the artifacts.
  </p>

  <ul>
    <li>
      <a href="quick-start.html">Quick Start</a>
    </li>
    <li>
      <a href="process-documentation.html">Process Documentation</a>
    </li>
    <li>
      <a href="integration-documentation.html">Integration Documentation</a>
    </li>
    <li>
      <a href="implementation-documentation.html">Implementation Documentation</a>
    </li>
    <li>
      <a href="service-documentation.html">Service Documentation</a>
    </li>
    <li>
      <a href="recommendation-01.html">2016 CDC Guideline Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration</a>
    </li>
    <li>
      <a href="recommendation-02.html">2016 CDC Guideline Recommendation #2 - Opioid Therapy Goals Discussion</a>
    </li>
    <li>
      <a href="recommendation-03.html">2016 CDC Guideline Recommendation #3 - Opioid Therapy Risk/Benefit Discussion</a>
    </li>
    <li>
      <a href="recommendation-04-order-sign.html">2016 CDC Guideline Recommendation #4 - Opioid Immediate Release Form When Starting Opioid Therapy</a>
    </li>
    <li>
      <a href="recommendation-05.html">2016 CDC Guideline Recommendation #5 - Lowest Effective Dose</a>
    </li>
    <li>
      <a href="recommendation-06.html">2016 CDC Guideline Recommendation #6 - Prescribe Lowest Effective Dose and Duration</a>
    </li>
    <li>
      <a href="recommendation-07.html">2016 CDC Guideline Recommendation #7 - Opioid Therapy Risk Assessment</a>
    </li>
    <li>
      <a href="recommendation-08.html">2016 CDC Guideline Recommendation #8 - Naloxone Consideration</a>
    </li>
    <li>
      <a href="recommendation-09.html">2016 CDC Guideline Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions</a>
    </li>
    <li>
      <a href="recommendation-10-order-sign.html">2016 CDC Guideline Recommendation #10 - Urine Drug Testing</a>
    </li>
    <li>
      <a href="recommendation-11-order-select.html">2016 CDC Guideline Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines</a>
    </li>
    <li>
      <a href="recommendation-12.html">2016 CDC Guideline Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder</a>
    </li>
  </ul>
</div>
